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Objective: To determine factors that inﬂuence quality of life in prostate cancer patients.
Patients and methods: Patients with pathologically veriﬁed prostate cancer and treated at the National
Cheng Kung University Hospital were invited to ﬁll out the World Health Organization Quality of Life-
BREF questionnaires at the outpatient clinic. We explored the determinants of quality of life including
age, education, income, marital status, disease stage, and treatment modality using a mixed-effects
model.
Results: From January 2013 to July 2014, a total of 248 patients were investigated and 404 measurements
were performed. Among them, there were 110 patients, 48 patients, and 90 patients with localized,
locally advanced, and metastatic disease, respectively. After adjustment for comorbidities and other
confounders, patients who were married showed a signiﬁcantly higher score in the domains of physical
health, social relationships including sexual satisfaction, and opportunities to obtain information and
leisure activities. A higher income was associated with a higher score in physical, psychological, and
environment domains. Patients with metastatic disease showed lower scores in the physical domain.
Conclusion: Our data demonstrated that marital status is an important determinant of quality of life in
prostate cancer patients besides other sociodemographic factors. Clinicians are advised to provide more
social support recourses for patients who do not have a partner.
Copyright © 2016, Taiwan Urological Association. Published by Elsevier Taiwan LLC. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Prostate cancer is amajormalignancy ofmen in theUnited States
and other developed countries.1 It has also become a major male
malignancy in Asia, including Taiwan.2,3 There are several charac-
teristics in Asian patients that differ fromwestern countries, such as
stage distribution, attitude to therapy modality, and response to
androgen deprivation therapy.4e6 Unlike other human malig-
nancies, the life span of prostate cancer patients is longer, particu-
larly those patients detected from prostate-speciﬁc antigen (PSA)
screening.7 Quality of life (QOL) improvement has become another
important goal in prostate cancer treatment. Many studies havetional Cheng Kung University
ity Road, Tainan 701, Taiwan.
ealth, National Cheng Kung
, University Road, Tainan 701,
Tsai), jdwang121@gmail.com
ociation. Published by Elsevier Tafocused on QOL in speciﬁc issues, including sexual dysfunction,8e10
urinary incontinence,9,10 and bowel changes9,10 which are therapy-
related, or on discussing anxiety raised by PSA screening.11 How-
ever, studies involving general aspects are not abundant.
To investigate the determinants that inﬂuence general QOL in
prostate cancer patients, we conducted this study by collecting and
analyzing patients' self reported questionnaires of the World
Health Organization Quality of Life- BREF (WHOQOL-BREF) Taiwan
version at an outpatient clinic, which can improve the under-
standing of disease-impacted general QOL for both urologists and
patients and provide some insightful information for decision-
making in the clinical care of prostate cancer patients.2. Patients and methods
2.1. Patient population
The current study was approved by the Institutional Review
Board of the National Cheng Kung University Hospital, Tainan,iwan LLC. This is an open access article under the CC BY-NC-ND license (http://
Y.-L. Kao et al. / Urological Science 26 (2015) 254e258 255Taiwan, after commencement. For a global view of real-world data,
we invited every patient with prostate cancer who came to the
urologic clinic of the National Cheng Kung University Hospital to
join the study from January 2013 to July 2014. The studied patients
included those immediately before transrectal ultrasound-guided
prostate biopsy, undergoing androgen deprivation therapy for
metastatic prostatic cancer, and patients after deﬁnite therapy such
as radical prostatectomy, radiation therapy, or under active sur-
veillance/observation. Patients who were immediately before
transrectal ultrasound-biopsy that later turned out to be malig-
nancy were included for their innate difference between patients
with benign disease. They also served as a baseline for analysis on
the impacts of QOL among different treatment strategies. After
obtaining each patient's consent, they were requested to ﬁll out the
questionnaires of WHOQOL-BREF. Repeated measurements in the
same individual at different times were conducted to reﬂect the
dynamic changes of QOL under different conditions.
2.2. WHOQOL-BREF questionnaires
The brief version of the WHOQOL-BREF is a generic question-
naire composed of two items from the Overall Quality of Life and
General Health facet and one item from each of the remaining 24
facets.12 These facets are classiﬁed into four major domains:
physical capacity (7 items), psychological well-being (6 items),
social relationships (3 items), and environment (8 items). In
compliance with the WHO guidelines, the Taiwanese version of the
WHOQOL-BREF was developed.13 In 2000, the excellent reliability
and validity of this version was published.14 In addition to
comprising 26 items translated from the original WHOQOL-BREF,
the Taiwanese version also contains two additional items of local
importance, i.e., being respected and food availability.14 The two
local items are categorized in the social relationships (being
respected) and environment (food availability) domains, respec-
tively. The WHOQOL-BREF Taiwan version was used in this study
for evaluation of general QOL. Each item is scored as a 5-level Likert
scale ranging from 1 to 5, and a higher score generally represents a
better QOL. Three items are reversely coded (items 3, 4, and 26).
Domain scores were calculated as the mean of items in each
domain and multiplied by four with a total sum ranging from 4 to
20, which were converted into a 0e100-range in the statistical
analysis.
2.3. Statistical analyses
In addition to the collection of QOL responses, we also
abstracted demographic and clinical data including age, education,
economic income, marital status, comorbidity of cardiovascular
disease, patients' categorization (divided into localized, locally
advanced, and distant metastasis), and treatment modalities (i.e.,
active surveillance, after radical prostatectomy, after radiotherapy,
or under long-term androgen deprivation therapy). Because of the
small sample size, patients with more than one positive lymph
node without evidence of distant metastasis were classiﬁed into
the locally advanced disease state.
The chi-square test was applied for the difference of determi-
nant distribution among different groups and p < 0.05 was
considered as statistically signiﬁcant. For each independent vari-
able, we selected one as the reference in the category for compar-
ison: age at interview (<65 years, 65e74 years, vs. 75 years),
education (>6 years vs. 6 years), marital status (conjugal vs.
nonconjugal), income (US$1667/mo vs. >US$1667/mo), and car-
diovascular comorbidities (yes vs. no). By assuming a linear auto-
correlation for repeated measurements within individual patients
and using the scores for each domain and individual item as thedependent variables, mixed-effects models were constructed. The
result was viewed as statistically signiﬁcant for p < 0.05. All data
were collected and analyzed using version 9.2 of SAS software (SAS
Institute, Cary, NC, USA).
3. Results
A total of 248 cases were enrolled during the 19-month period
with 404 measurements performed. Table 1 summarizes frequency
distribution among the participants stratiﬁed by different stages.
Our sample contains a slightly higher proportion of patients with
distant metastasis, however, the distribution appears similar to the
national prostate cancer population (Table 2). Generally, the major
characteristics of patients' measurements were patients aged > 65
years, with localized or metastatic disease, married with relatively
low income, or without cardiovascular disease (Table 1).
3.1. Mixed-effects model analysis for QOL of prostate cancer
The results of the mixed-effects model were summarized for the
scores of domains (Table 3) and items (Table 4), respectively. We
found that patients of a younger age (<65years) had a higher score
in the physical domain than older patients (75 years), of which
they had a higher score on mobility and were less dependent on
medical aids. Patients with a monthly income <US$1667 showed
lower scores in the physical, psychological, and environment do-
mains. A detailed analysis for different items showed signiﬁcantly
lower scores in mobility, dependence on medical aids, and working
capacity of the physical domain; lower scores in positive feelings,
self-esteem, and spirituality/beliefs of the psychological domain; as
well as the same trend of ﬁnancial resources, participation in and
opportunities for recreation/leisure activities of the environment
domain. Patients who were married or conjugal at the time of
interview expressed higher scores on the physical (mainly mobility
item) and social domain (mainly item of sexual activity). Patients
with distant metastasis had lower scores in the physical domain,
especially the items of pain and discomfort, energy and fatigue,
mobility, sleep, and rest compared with patients in the localized
cancer group. In terms of treatment modality, patients receiving
radical prostatectomy had signiﬁcantly lower scores in the item of
sexual activity and being respected of the social domain, however,
they had less pain/discomfort and a higher overall score of QOL.
4. Discussion
In this study, we tried to control potential confounding factors
through construction of a mixed-effects model. The effects of both
general factors (age, education, personal income, marital status,
comorbidity of cardiovascular disease) and disease speciﬁc factors
(cancer group, treatment group) on QOL in patients with prostate
cancer were analyzed.
We demonstrated that both general and disease speciﬁc factors
had an inﬂuence on QOL of prostate cancer patients, including age,
personal income, marital status, disease status, and treatment
modality, respectively, which corroborate previous studies.15,16 The
effects of education on the four major domains of QOL were not
signiﬁcant in this study, apparently because of the small sample
size that precludes us from classifying into more strata. As ex-
pected, younger patients or less disease-advanced patients had
better energy coping with daily life activities. Personal income also
had strong positive inﬂuences on the scores of the physical, psy-
chological, and environment domains. As Table 2 shows, the de-
mographic and clinical stage distributions of our participants were
similar to the national prostate cancer population of Taiwan,17
hence the generalizability of our ﬁndings for QOL seem
Table 1
Frequency distribution of the study patients with prostate cancer stratiﬁed by stages.
Localized Locally advanced Distant metastasis p
(N ¼ 110) (N ¼ 48) (N ¼ 90)
n (%) n (%) n (%)
Age (y) 0.14
<65 20 (18) 11 (23) 20 (22)
65e74 54 (49) 14 (29) 32 (36)
75 36 (33) 23 (48) 38 (42)
Education (y) 0.27
6 52 (48) 16 (33) 39 (43)
>6 58 (52) 32 (67) 51 (57)
Personal income 0.86
US$1667/mo 89 (81) 38 (79) 70 (78)
>US$1667/mo 21 (19) 10 (21) 20 (22)
Marital status 0.22
Single/divorced/widowed 16 (15) 3 (6) 15 (17)
Married 94 (85) 45 (94) 75 (83)
Comorbidity of cardiovascular disease 0.86
No 98 (89) 44 (92) 80 (89)
Yes 12 (11) 4 (8) 10 (11)
Table 2
Demographic characteristics of patients with prostate cancer at the National Cheng Kung University Hospital and those registered on the cancer registry in Taiwan.
Disease status Cancer registry (N ¼ 3847) NCKUH (N ¼ 248) NCKUH (N ¼ 404 measurements) a
Year of study 2011 2013e2014 2013e2014
Age (y) 73.1 ± 9.3 71.6 ± 8.3 71.4 ± 8.3
Localized 1790 (46.5) 110 (44.4) 171 (42.3)
Locally advanced 699 (18.2) 48 (19.4) 79 (19.6)
Distant metastasis 1296 (33.7) 90 (36.3) 154 (38.1)
Unknown 62 (1.6) 0 0
Data are presented as mean ± SD or n (%).
NCKUH ¼ National Cheng Kung University Hospital; SD ¼ standard deviation.
a Including 156 repeated measurements among the original 248 patients.
Table 3
Determinants of quality of life in prostate cancer patients using a mixed-effects model analysis.
Physical health Psychological Social relationship Environment
b^(SE) ^b(SE) ^b(SE) ^b(SE)
Age (y)
<65 1.70 (0.70) * 0.08 (0.60) 0.46 (0.49) 1.35 (0.98)
65e74 1.07 (0.59) 0.05 (0.50) 0.44 (0.41) 0.67 (0.82)
75 Ref Ref Ref Ref
Education (y)
6 Ref Ref Ref Ref
>6 0.72 (0.55) 0.62 (0.47) 0.32 (0.38) 1.06 (0.77)
Personal income
US$1667/mo 1.74 (0.66) * 1.63 (0.57) ** 0.23 (0.47) 2.01 (0.94) *
>US$1667/mo Ref Ref Ref Ref
Marital status
Nonconjugal Ref Ref Ref Ref
Conjugal 1.79 (0.77) * 0.26 (0.66) 2.41 (0.54) ** 1.97 (1.08)
Comorbidity of cardiovascular disease
No Ref Ref Ref Ref
Yes 0.53 (0.88) 0.34 (0.76) 0.36 (0.62) 0.12 (1.24)
Cancer group
Localized Ref Ref Ref Ref
Local advanced 1.09 (0.71) 0.21 (0.61) 0.06 (0.50) 0.52 (1.00)
Distant metastatic 2.96 (0.84)** 1.24 (0.73) 0.27 (0.59) 1.84 (1.19)
Treatment group
Biopsy & active surveillance Ref Ref Ref Ref
Radical prostatectomy 0.32 (0.86) 0.06 (0.74) 1.31 (0.60) * 0.95 (1.20)
Radiotherapy 0.80 (0.73) 0.10 (0.63) 0.79 (0.52) 0.90 (1.03)
ADT & chemotherapy 1.23 (0.82) 1.09 (0.71) 0.40 (0.58) 1.48 (1.16)
* p < 0.05.
** p < 0.005.
^b ¼ regression coefﬁcient; ADT ¼ androgen deprivation therapy; Ref ¼ as a reference group; SE ¼ standard error.
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Table 4
Regression coefﬁcients (^ b) and standard error (in parentheses) based on construction of the mixed-effects model for each facet and domain of the WHOQOL-BREF.
Domain Facet Age < 65 y a Low income b Conjugal c Distant metastasis d Radical prostatectomy e
Overall QOL 0.27 (0.13) *
Overall health 0.42 (0.15)*
Physical
Pain and discomfort f 0.73 (0.17) ** 0.43 (0.18) *
Dependence on medical aids f 0.57 (0.17) ** 0.46 (0.16) ** d
Energy 0.38 (0.18) *
Mobility 0.39 (0.15) * 0.34 (0.15) * 0.46 (0.17) * 0.42 (0.19) *
Sleep and rest 0.44 (0.18) *
ADL
Working capacity 0.36 (0.15) *
Psychological
Positive feelings 0.40 (0.14) **
Spirituality/beliefs 0.34 (0.14) *
Self-esteem 0.40 (0.13) **
Negative feelings f 0.49 (0.19) *
Social
Being respected 0.41 (0.17) *
Sexual activity 1.10 (0.25) ** 0.44 (0.22) *
Environment
Safety and security 0.34 (0.16) *
Financial resources 0.72 (0.14) **
Acquiring information 0.31 (0.14) * 0.33 (0.16) *
Recreation activities 0.39 (0.16) * 0.41 (0.18) *
Transport 0.28 (0.12) *
* p < 0.05.
** p < 0.005.
ADL ¼ activity of daily living; QOL ¼ quality of life; WHOQOL-BREF ¼World Health Organization Quality of Life- BREF.
a Age  75 years as reference.
b >US$1667/mo as reference.
c Single/divorced/widowed as reference.
d Localized disease as reference.
e Biopsy and active surveillance.
f Reversely coded item converted to higher score means better QOL.
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monthly income of US$1667 and an education of 6 years were
lower than those of the general population of Taiwan reported by
the Department of Ministry, Executive Yuan (78.45% and 42.47% vs.
69.51% and 28.51%, respectively).18,19 As a result, the QOL of these
prostate cancer patients would be affected, which must be kept in
mind when comparing our results with the national survey.
Although one European study focusing on the prediction of QOL
in a small cohort of 103 prostate cancer patients did not demon-
strate any signiﬁcant difference among those with and without a
living partner,20 another study from Brazil collected data from 32
patients and did not show the same trend.21 As the sample sizes of
both studies were small, controversy still exists. By contrast, several
studies found favorable survival in prostate cancer patients with
married status based on data collected in the Surveillance, Epide-
miology, and End Results database.22 Further analysis focusing on
the top 10 leading cancer deaths from the Surveillance, Epidemi-
ology, and End Results database demonstrated that married pa-
tients had lower metastatic disease at initial presentation, a higher
proportion receiving deﬁnite treatment, and less cancer-speciﬁc
mortality. Such ﬁndings suggest the potential impacts of social
support (i.e., marital status) on cancer detection, treatment, and
survival.23 The study also highlights that a greater beneﬁt is asso-
ciated with marriage in males than females. Our study, based on a
total of 404 measurements, demonstrated that marriage and/or
cohabitation had positive inﬂuences on physical health and social
relationships of prostate cancer patients, especially on items of
mobility, activities of daily living, and sexual activity. Furthermore,
a signiﬁcant increase in facets of acquiring new information and
skills and opportunities for recreation activities were also noted.
These ﬁndings support the positive impacts of social support in
cancer outcome. Several studies in the elderly or breast cancerpatients also showed the link between better QOL and marital
status.15,16 Thus, we tentatively conclude that marriage, or living
with an intimate partner, would improve the QOL of patients with
prostate cancer; however, a large scale study is needed to corrob-
orate this hypothesis.
With the exception of lower social relationships in patients after
radical prostatectomy (including poor sexually activity and poor
feeling of respect), there was no signiﬁcant difference in domain
scores in terms of treatment modalities while patients on active
surveillance served as a reference group. Although the question-
naire used was not speciﬁc for treatment complications, some
studies have also reported worse sexual function in patients after
radical prostatectomy compared with other treatments such as
radiotherapy.24,25
Therewere some limitations to the current study. Firstly, it was a
cross-sectional survey without subgrouping such as, various pe-
riods from diagnosis or treatment to evaluation, or detailed disease
status in progression/recurrence or not. Despite this, we adjusted
major predictive factors such as disease stage, treatment modal-
ities, and comorbidity to minimize the potential confounding. We
have planned an ongoing study for comparison between pre- and
post-treatment (radiotherapy, radical prostatectomy) impacts of
QOL plus PSA correction of disease status for more speciﬁc corre-
lation between prostate cancer and QOL. Secondly, we arbitrarily
designated node-positive patients into the locally advanced group
due to the small patient numbers, which may have some inﬂuence
over the results. However, there is still debate on whether lymph
node positive should be considered as metastatic disease in pros-
tate cancer.26,27 Finally, our samples were recruited from a single
institution. Limitation in sample size does exist, particularly in
speciﬁc stratiﬁcation such as locally advanced and comorbidity of
cardiovascular disease. These minority groups split our sample size
Y.-L. Kao et al. / Urological Science 26 (2015) 254e258258into a more fragmentary one. We plan to increase case numbers
both in our own center and through union with other medical
centers in Taiwan in the future to make the results more general-
izable throughout Taiwan.
In conclusion, our study provided a more general evaluation of
prostate cancer patients of all stages. We found that marital status
played an important positive role in patients' health-related QOL in
prostate cancer patients from south Taiwan. Patients within a
partnership showed signiﬁcant increases in the physical, social, and
part of the environment domains of QOL after adjusting for other
confounding factors. A plausible explanation may be the result
from having positive social support both in medical care and
health-related QOL by the intimate partner living with the patients.
Physicians caring for prostate cancer patients should pay more
attention to providing psychological counseling or social/emotional
support during clinical practice for those without any support from
partnerships.
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